CSI Market
Sign In | Register

Spyre Therapeutics Inc (SYRE) Annual Balance Sheets

Annual · GAAP · USD millions
Access SYRE quarterly Balance Sheets →
Quarterly balance sheet trends provide context on Spyre Therapeutics Inc's liquidity, leverage, and long-term financial structure.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/SYRE/balance-sheets
https://api.csimarket.com/api/v1/companies/SYRE/fundamentals
https://api.csimarket.com/api/v1/companies/SYRE/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent85.72
Available-for-sale Securities, Debt Securities, Current MA670.81
Cash & Short-term Investments755.00
Notes Receivable, Current0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current21.25
Total Current Assets777.78
Equipment/Property/Plant Net0.00
Other Assets, Noncurrent0.00
Restricted Cash Noncurrent-
Operating Lease Right Of Use Asset-
Total Assets777.78
Liabilities
Accounts Payable, Current AC8.90
Accrued Liabilities And Other Liabilities26.95
Derivative Liability, Current DE22.82
Other Liabilities, Current0.01
Deferred Liability and Revenue0.00
Total Current Liabilities58.69
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE3.86
Deferred credits, Noncurrent0.00
Other liabilities, Noncurrent0.00
Operating Lease Liability Current-
Operating Lease Liability Noncurrent-
Total Liabilities62.55
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock1,686.17
Retained Earnings / Accumulated Deficit-1,127.64
Other Equity10.26
Common Stockholder's Equity568.81
Preferred Stockholder's Equity146.43
Non-controlling interests & other0.00
Total Stockholder's Equity715.24
Liabilities & Stockholder's Equity777.78
4 historic quarters locked

Sign in to unlock the full Spyre Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Spyre Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 19, 2026
  • Source: syre-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001636282-26-000020

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI